175 related articles for article (PubMed ID: 17526990)
1. Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure.
Tsutamoto T; Sakai H; Tanaka T; Fujii M; Yamamoto T; Wada A; Ohnishi M; Horie M
Circ J; 2007 Jun; 71(6):915-21. PubMed ID: 17526990
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of plasma renin activity in heart failure.
Vergaro G; Emdin M; Iervasi A; Zyw L; Gabutti A; Poletti R; Mammini C; Giannoni A; Fontana M; Passino C
Am J Cardiol; 2011 Jul; 108(2):246-51. PubMed ID: 21545993
[TBL] [Abstract][Full Text] [Related]
3. Plasma renin activity is a strong and independent prognostic indicator in patients with acute decompensated heart failure treated with renin-angiotensin system inhibitors.
Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
Circ J; 2015; 79(6):1307-14. PubMed ID: 25753468
[TBL] [Abstract][Full Text] [Related]
4. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure.
Fung JW; Yu CM; Yip G; Chan S; Yandle TG; Richards AM; Nicholls MG; Sanderson JE
Am J Cardiol; 2003 Aug; 92(4):406-10. PubMed ID: 12914870
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).
Masson S; Solomon S; Angelici L; Latini R; Anand IS; Prescott M; Maggioni AP; Tognoni G; Cohn JN;
J Card Fail; 2010 Dec; 16(12):964-70. PubMed ID: 21111986
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.
Benedict CR; Shelton B; Johnstone DE; Francis G; Greenberg B; Konstam M; Probstfield JL; Yusuf S
Circulation; 1996 Aug; 94(4):690-7. PubMed ID: 8772689
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease.
Poletti R; Vergaro G; Zyw L; Prontera C; Passino C; Emdin M
Int J Cardiol; 2013 Aug; 167(3):711-5. PubMed ID: 22459392
[TBL] [Abstract][Full Text] [Related]
10. Low- and High-renin Heart Failure Phenotypes with Clinical Implications.
Pavo N; Goliasch G; Wurm R; Novak J; Strunk G; Gyöngyösi M; Poglitsch M; Säemann MD; Hülsmann M
Clin Chem; 2018 Mar; 64(3):597-608. PubMed ID: 29138270
[TBL] [Abstract][Full Text] [Related]
11. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
Yasumura Y; Miyatake K; Okamoto H; Miyauchi T; Kawana M; Tsutamoto T; Kitakaze M; Matsubara H; Takaoka H; Anzai T; Himeno H; Yokoyama H; Yokoya K; Shintani U; Hashimoto K; Koretsune Y; Nakamura Y; Imai K; Maruyama S; Masaoka Y; Sekiya M; Shiraki T; Shinohara H; Ozono K; Matsuoka T; Miyao Y; Nomura F
Circ J; 2004 Apr; 68(4):361-6. PubMed ID: 15056835
[TBL] [Abstract][Full Text] [Related]
13. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
Tsutamoto T; Wada A; Maeda K; Hisanaga T; Fukai D; Maeda Y; Ohnishi M; Mabuchi N; Kinoshita M
Am Heart J; 1997 Nov; 134(5 Pt 1):910-6. PubMed ID: 9398103
[TBL] [Abstract][Full Text] [Related]
14. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
[TBL] [Abstract][Full Text] [Related]
15. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
[TBL] [Abstract][Full Text] [Related]
16. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
17. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Kjaer A; Hesse B
Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
[TBL] [Abstract][Full Text] [Related]
19. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction.
Stanek B; Frey B; Hülsmann M; Berger R; Sturm B; Strametz-Juranek J; Bergler-Klein J; Moser P; Bojic A; Hartter E; Pacher R
J Am Coll Cardiol; 2001 Aug; 38(2):436-42. PubMed ID: 11499735
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
